DCM
OXFD

Delpha Capital Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Delpha Capital Management’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-79
Closed -$1K – 1484
2017
Q4 		$1K Buy
+79
New +$1.16K ﹤0.01% 1619

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Delpha Capital Management's OXFD Position: Q1 2018 in Review

Delpha Capital Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2018, closing a stake of 79 shares — an estimated $1K sold.

Delpha Capital Management first reported a position in OXFD in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 74 funds tracked by Wall St. Rank hold OXFD as of Q1 2018.

  • Delpha Capital Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 79 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2018, an estimated $1K.
  • Delpha Capital Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1K in Q4 2017.
  • 74 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.